Cocrystal Pharma (COCP) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Nov 1, 2026

Net buying: insiders sold $0 and bought $80K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: +$80K netNet buying
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about COCP filings

Are insiders buying or selling Cocrystal Pharma Inc (COCP) stock?

Net buying: insiders sold $0 and bought $80K of COCP stock on the open market in the 90 days to Nov 1, 2026, according to SEC Form 4 filings. The largest was Frost, Phillip Md Et Al (Director), who bought $80K. The latest filing was on Aug 6, 2026.

Which members of Congress have traded COCP recently?

None. No member of Congress disclosed a COCP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COCP smart-money data?

This summary uses filings available on Nov 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

Smart money on COCP

Lean long1 source:
- Insiders

Top traders
No tracked positions at the last update
Insiders
- Phillip Md Et Al Frost, bought $70.6K, open market, filed Aug 5
- Phillip Md Et Al Frost, bought $9.8K, open market, filed Aug 6
Lean long · thin2 buys · $80.4K
Form 4 filings, open market.
Politicians
No recent politician filings found
Funds
No recent fund filings found
Fin-fluencers
No recent posts found

Each bar is 100% of that source’s money. The notch marks an even split.

Lean is the direction of the latest moves. Descriptive, not advice.

Questions about COCP filings

Are insiders buying or selling Cocrystal Pharma Inc (COCP) stock?

Which members of Congress have traded COCP recently?

None. No member of Congress disclosed a COCP trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this COCP smart-money data?

Insiders

What insiders are doing

2 trades · 6 mo

Bought$80K

Buys (2)

FP
Frost Phillip Md Et Al
Dir, 10% · Held by Frost Gamma Investments Trust · Aug 6
$10K
bought
FP
Frost Phillip Md Et Al
Dir, 10% · Held by Frost Gamma Investments Trust · Aug 5
$71K
bought
Signals like this: n=2387, 51% finished lower at D15, median -0.3% vs SPY +0.3%

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Earnings came in 39.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.23-39.39% miss

-$0.17 expected

Revenue

$105.0K

SEC filing

EPS: Yahoo Finance

Next report

Estimated report: Nov 13, 2026, in 12 days

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	-$0.23est. -$0.17	-39.39%miss	$105.0KSEC filing	No year-ago quarter
Mar 31, 2026Reported May 15, 2026	-$0.17est. -$0.15	-13.33%miss	$225.0KSEC filing	No year-ago quarter
Dec 31, 2025Reported Mar 31, 2026	-$0.17est. -$0.17	+2.86%beat	$0.00Yahoo Finance	No year-ago quarter
Sep 30, 2025Reported Nov 14, 2025	-$0.19est. -$0.21	+11.63%beat	$0.00Yahoo Finance	No year-ago quarter
Jun 30, 2025Reported Aug 14, 2025	-$0.20est. -$0.30	+33.33%beat	Not on file	Not on file
Mar 31, 2025Reported May 15, 2025	-$0.23est. -$0.52	+55.77%beat	Not on file	Not on file
Dec 31, 2024Reported Mar 31, 2025	-$0.32est. -$0.53	+39.62%beat	Not on file	Not on file
Sep 30, 2024Reported Nov 13, 2024	-$0.49est. -$0.57	+14.04%beat	Not on file	Not on file

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

Open: $0.92
52-wk high: $2.03
High: $1.07
52-wk low: $0.76
Low: $0.92
Prev close: $0.91
Mkt cap: $19.2M
ROE: -311.7%
Beta: 1.48
P/S: 58.1x
P/B: 18.1x
Profit margin: +0.0%
Op margin: -3032.0%

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $19M

Valuation

P/S58.08
P/B18.08

Quality

Operating margin-3032.0%
ROE-311.7%
ROA-96.1%

Growth

Beta1.48

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

23oversold

20D volatility

51%annualized

52-week range

$0.95

$0.76$2.03

20D support

$0.91recent floor

20D resistance

$1.24recent ceiling

Returns

5D -6.9%20D -18.8%60D +9.5%

Price vs moving averages

SMA20 -10.0%SMA50 -14.8%SMA200 -14.0%

Volume pace

0.81xvs prior 20D

Quarter / reported

Earnings per share

Beat or miss

Revenue / income

Revenue vs last year

Jun 30, 2026Aug 13, 2026

-$0.23est. -$0.17

-39.39%

$105.0KSEC filing

No year-ago quarter

Mar 31, 2026May 15, 2026

-$0.17est. -$0.15

-13.33%

$225.0KSEC filing

No year-ago quarter

Dec 31, 2025Mar 31, 2026

-$0.17est. -$0.17

+2.86%

$0.00Yahoo Finance

No year-ago quarter

Sep 30, 2025Nov 14, 2025

-$0.19est. -$0.21

+11.63%

$0.00Yahoo Finance

No year-ago quarter

Jun 30, 2025Aug 14, 2025

-$0.20est. -$0.30

+33.33%

Not on file

Mar 31, 2025May 15, 2025

-$0.23est. -$0.52

+55.77%

Not on file

Dec 31, 2024Mar 31, 2025

-$0.32est. -$0.53

+39.62%

Not on file

Sep 30, 2024Nov 13, 2024

-$0.49est. -$0.57

+14.04%

Not on file

Cocrystal Pharma Inc

Smart money at a glance

What do analysts expect?

Questions about COCP filings

Smart money on COCP

Questions about COCP filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 39.4% below what analysts expected.

Estimated report: Nov 13, 2026, in 12 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cocrystal Pharma Inc

Smart money at a glance

What do analysts expect?

Questions about COCP filings

Smart money on COCP

Questions about COCP filings

What insiders are doing

How top traders are positioned

Unlock everything for $29/month

Earnings came in 39.4% below what analysts expected.

Estimated report: Nov 13, 2026, in 12 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Cocrystal Pharma Inc

Overview

Questions about COCP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Cocrystal Pharma Inc

Overview

Questions about COCP filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.